SeaDragon announces Director changes

SeaDragon Limited (NZX:SEA) today announces the resignation of Matt McNamara from the Board of Directors, with effect from the 20th of December 2019. Matt originally joined the Board in October 2012 and has represented substantial shareholder BioScience Managers as a director for the last seven years providing critical insights from his experience in other healthcare and medical sciences businesses. Chairman Bryan Mogridge said: "The Board would like to thank Matt for his support during the recent transition of the business into the Omega-3 market and his contribution to the future growth and development of our company." Jeremy Curnock Cook, who until this resignation was an alternate Director to Matt McNamara, will continue to represent BioScience Managers. At SeaDragon's next meeting of shareholders, shareholders will be asked to formally elect Jeremy Curnock Cook as a Director. For the purposes of NZX Main Board Listing Rule 2.6.1, the Board has determined that Jeremy Curnock-Cook is not an Independent Director. For further information contact: Bryan Mogridge Chairman Tel: +64 21 931 355 About SeaDragon: www.seadragon.co.nz SeaDragon Limited (NZX:SEA) is New Zealand's largest refiner and blender of high-quality, internationally certified concentrated fish oils and fractions, including Omega-3 oils. Our oils are sourced from fish caught in the clean and pure waters around New Zealand, in the Southern Ocean, and elsewhere. We have more than 20 years' experience processing fish oils and we are recognised for the quality and purity of our products. We supply health supplement manufacturers around the world to meet the burgeoning demand for pure, high-quality fish oils, which are scientifically proven to deliver significant human health benefits such as lowering the risk of heart disease, improving brain function and joint health. The majority of our supply is exported. End CA:00346431 For:SEA Type:ADMIN Time:2019-12-20 15:10:20